Cell Therapy Liaison Meeting Resources

FDA Cell Therapy Liaison Meeting (CTLM)

 

Since 2004, ISCT has been the host organization leading over 20 invited stakeholder organizations in an annual face-to-face meeting with the FDA Cell Therapy Liaison Meeting (CTLM). These closed meetings enable the cell and gene therapy community, and industry to inform the FDA of specific concerns, challenges and recent developments to advance the regulatory field. 

For more information and past meeting summaries, click here

Health Canada Biologics and Genetic Therapies Directorate (BGTD) and Cell Therapy Stakeholder Group (CTSG) Bilateral Meeting

 

Since 2015, ISCT participates in bilateral meetings with the Health Canada BGTD and national stakeholder organizations in Canada in an effort to improve interactions between health care and the cell and gene therapy community as well as to improve the navigation of regulations and discuss challenges in the field. .

For more information and past meeting summaries, click here


© 2019 ISCT. All rights reserved. 
ISCT, and the ISCT logo are registered trademarks of the International Society for Cellular Therapy.
The BEACON and lighthouse logo is a service mark of the International Society for Cellular Therapy.

ISCT Privacy Policy